Germany’s IQWiG Approves Eliquis For AF, But Restricts Its Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany’s HTA IQWiG has approved Bristol/Pfizer’s Eliquis (apixaban) for atrial fibrillation but restricted the oral anticoagulant’s indication, leaving a potential gap for its rivals to fill.